Canaccord Genuity Maintains a 'Buy' on GenMark Diagnostics (GNMK); Q2 Preview: Expecting Really Good Numbers
Tweet Send to a Friend
Canaccord Genuity maintains a 'Buy' on GenMark Diagnostics (NASDAQ: GNMK) price target of $12.00.
Analyst, Jeffrey Frelick, said, "We ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Analyst, Jeffrey Frelick, said, "We ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
